SmartDose® Self Injection Platform
![smartdose smartdose](https://vertassets.blob.core.windows.net/image/4f279ae5/4f279ae5-aaf4-40be-ad93-f5b6dbb34a85/375_250-smartdose.jpg)
Consistent. Reliable. Ready to Go. The first combination product that incorporates the SmartDose Platform was recently approved by the U.S. Food and Drug Administration (FDA). West developed SmartDose® for single-use drug delivery. This wearable device is a patient-centric drug delivery device that incorporates human factors design and usability testing. The SmartDose platform is usually worn on the abdomen and pre-programmed to deliver highly viscous biologics to the patient.
SmartDose Platform highlights:
- Ideal for high-viscosity and silicone-sensitive biologic formulations
- Includes a Daikyo Crystal Zenith primary drug container with FluroTec elastomer coating
- Dual site commercial manufacturing
- Injectable Volume Range: 3.7mL
- Wear Time: Up to 2 hours
- Minimum Delivery Time: 4.5 minutes
For more information on West Pharmaceutical Services SmartDose Self-Injection Platform please visit: http://www.westpharma.com/products/self-injection-platforms/smartdose
West Pharmaceutical Services, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more